| | | | | |
AVTX Avalo Therapeutics, Inc. Common Stock | €11,7080 | -1,06% | €722,04M | €1,15M | |
| €41,3893 | +3,53% | €721,62M | €112,31K | |
| €17,8182 | +4,87% | €720,57M | €376,81K | |
EVC Entravision Communication | €7,8197 | +5,58% | €719,71M | €1,85M | |
ETON Eton Pharmaceutcials, Inc. Common Stock | €24,8973 | +4,71% | €718,32M | €619,72K | |
| €23,3730 | +4,99% | €716,71M | €145,03K | |
AMPH Amphastar Pharmaceuticals, Inc. | €16,1044 | +3,20% | €715,78M | €395,48K | |
MATW Matthews International Corp | €21,9520 | +0,20% | €713,17M | €171,16K | |
TBPH Theravance Biopharma, Inc. | €14,0935 | +2,80% | €713,02M | €352,88K | |
MPB Mid Penn Bancorp, Inc. | €27,9201 | +2,89% | €712,65M | €109,75K | |
KRO Kronos Worldwide, Inc. | €5,9078 | -2,97% | €712,41M | €197,41K | |
ADAM Adamas Trust, Inc. Common Stock | €7,8369 | +3,53% | €711,97M | €449,94K | |
CAPL CrossAmerica Partners LP Common units representing limited partner interests | €19,8442 | +5,26% | €710,40M | €49,08K | |
ROOT Root, Inc. Class A Common Stock | €45,2733 | +0,38% | €709,55M | €146,87K | |
EOI Eaton Vance Enhanced Equity Income Fund | €17,1293 | +0,51% | €709,03M | €38,47K | |
